Open-Labeled Study of PSI-7977 and RBV With and Without PEG-IFN in Treatment-Naïve Patients With HCV GT2 or GT3
This study is currently recruiting participants.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01260350
Contacts
Contact: Fiona Mackay, BSc 6498171460 fiona.mackay@beltas.com
Contact: Robert Sorensen 609-613-4100 rsorensen@pharmasset.com
Locations
New Zealand
Auckland Clinical Studies Ltd. Recruiting
Auckland, New Zealand
Contact: Ed Gane, Assoc. Prof
Principal Investigator: Ed Gane, Assoc. Prof
Christchurch Clinical Studies Trust Recruiting
Christchurch, New Zealand
Contact: Catherine Stedman, MD
Principal Investigator: Catherine Stedman, MD
No comments:
Post a Comment